This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
CONFIRM
MENU
CLOSE
language
Powerful, accessible cell therapies for patients with cancer.

We develop innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
FIND US
Acepodia USA
1600 Harbor Bay Parkway, Suite 140,
Alameda, CA 94502,
USA
Acepodia Taiwan
12F., No. 508, Sec. 7, Zhongxiao E. Rd.,
Nangang Dist., Taipei City 115011,
Taiwan (R.O.C.).
CONTACT US
Tel: +1 (415) 366 7822 Email: info@acepodiabio.com
FOLLOW US
Copyright © 2020 Acepodia Inc.
Privacy Policy Terms of use

AD2C

Program
Discovery
Preclinical
Phase I
Phase II
AD2C-Oncology
targeting GPC3 for HCC
DETAILS
Preclinical ​

ACC-Oncology

Program
Discovery
Preclinical
Phase I
Phase II
ACE1831
CD20 Targeting, ACC-γδ2 T Cell Therapy
DETAILS
Phase I ​
ACE2016
EGFR Targeting, ACC-γδ2 T Cell Therapy
DETAILS
Phase I ​

ACC-Autoimmune

Program
Discovery
Preclinical
Phase I
Phase II
ACE1831
ACC-autoimmune diseases
DETAILS
Phase I ​
We have collaborated with biopharmaceutical partners and academic institutes worldwide.
CONTACT US